Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
24.56B | 26.31B | 23.08B | 21.26B | 19.52B | 19.28B | Gross Profit |
2.19B | 17.23B | 15.10B | 5.91B | 5.19B | 5.14B | EBIT |
2.36B | 2.69B | 2.57B | 2.05B | 1.87B | 1.70B | EBITDA |
3.35B | 3.97B | 3.45B | 2.81B | 2.91B | 2.41B | Net Income Common Stockholders |
1.84B | 1.96B | 1.86B | 1.59B | 1.76B | 1.30B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.32B | 3.38B | 4.11B | 3.36B | 3.11B | 2.96B | Total Assets |
24.75B | 38.14B | 32.06B | 31.46B | 27.14B | 27.94B | Total Debt |
4.30B | 10.15B | 6.48B | 6.86B | 6.36B | 6.68B | Net Debt |
1.07B | 6.78B | 2.47B | 3.75B | 3.44B | 3.91B | Total Liabilities |
19.13B | 26.36B | 21.34B | 19.06B | 18.66B | 22.34B | Stockholders Equity |
5.55B | 11.62B | 10.56B | 11.21B | 7.44B | 4.64B |
Cash Flow | Free Cash Flow | ||||
1.96B | 2.76B | 2.80B | 2.00B | 1.82B | 508.00M | Operating Cash Flow |
2.92B | 3.92B | 3.76B | 2.70B | 2.28B | 985.00M | Investing Cash Flow |
-5.07B | -5.27B | -541.00M | -548.00M | -14.00M | -2.08B | Financing Cash Flow |
1.79B | 695.00M | -2.19B | -2.06B | -1.99B | 1.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £2.33B | 17.51 | 14.44% | 1.98% | 10.36% | 32.77% | |
74 Outperform | $51.98B | 27.40 | 17.85% | 1.84% | 14.01% | 6.03% | |
74 Outperform | £4.23B | 21.96 | 44.03% | 0.63% | 3.34% | 481.76% | |
74 Outperform | £1.13B | 28.94 | 11.62% | 1.86% | 8.00% | 674.47% | |
72 Outperform | $67.06B | 26.33 | 0.73% | 14.70% | 3.76% | ||
70 Neutral | £1.76B | 41.77 | 4.71% | 2.39% | -0.68% | -78.93% | |
64 Neutral | $4.30B | 11.88 | 5.23% | 249.82% | 4.12% | -10.27% |